DOI: 10.1055/s-00000020

Geburtshilfe und Frauenheilkunde


Perez EA, Romond EH, Suman VJ. et al.
Trastuzumab plus adjuvant chemotherapy for human epidermal growth factor receptor 2-positive breast cancer: planned joint analysis of overall survival from NSABP B-31 and NCCTG N9831.

J Clin Oncol 2014;
32: 3744-3752

Download Bibliographical Data

Search in: